3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Deafness: new trials by email Literature Review of Deafness trials Research Report on Deafness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AM-111 in the Treatment of Acute Inner Ear Hearing Loss Placebo, AM-111 0.4 mg/ml, AM-111 0.8 mg/ml - Hearing Loss | Phase 3 | Completed | Auris Medical AG | 256 | 2015-11-01 | 2023-09-14 |
| Multicenter Trial Assessing an Innovative VAS of Pain Among Deaf People pictorial VAS, usual VAS - Deafness, Visual Analog Pain Scale | Phase 2 / Phase 3 | Completed | University Hospital, Grenoble | 289 | 2011-06-01 | 2013-07-23 |
| Protective Effect of N-acetylcysteine Against From Ototoxicity N-acetylcysteine - Hearing Loss, Extreme | Phase 2 / Phase 3 | Completed | TC Erciyes University | 60 | 2010-06-01 | 2011-11-16 |
Ear Diseases (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Unilateral (1) · Otorhinolaryngologic Diseases (1) · Ototoxicity (1) · Peritonitis (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Speech Disorders (1)
Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Ear Diseases (2) · Hearing Disorders (2) · Hearing Loss (2) · Otorhinolaryngologic Diseases (2) · Sensation Disorders (2) · Signs and Symptoms (2) · Chemically-Induced Disorders (1) · Communication Disorders (1) · Digestive System Diseases (1) · Drug-Related Side Effects and Adverse Reactions (1) · Infections (1) · Intraabdominal Infections (1)
Acetylcysteine (1) · D-JNKI-1 (1)
Auris Medical AG (1) · TC Erciyes University (1) · University Hospital, Grenoble (1)
Bulgaria (1) · France (1) · Turkey (Türkiye) (1)
Benoit Mongourdin, PH (1) · Ismail Kocyigit, MD (1)